Companies / Egypt
Egyptian Drug Market Facing Challenges
July 2006 | Market Trend AnalysisEgypt's pharmaceutical market was worth EGP11.5bn (US$1.94bn) in 2005 and is one of the largest in the Eastern Mediterranean region, second only to Turkey. However, government cost containment measures and the rising cost of raw materials has placed significant pressure on profit margins in recent years. Moreover, issues pertaining to intellectual property, and especially the lack of an effective data exclusivity and patent linkage system, continue to have a restrictive effect on market
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
